Table 5. Lists of contraindicated drug interactions and most common major drug interactions with potential effects according to Micromedex Drug Interaction Database.
Drug combination | Potential effects | (n = 1360) N (%) |
---|---|---|
Contraindicated drug interactions | ||
Haloperidol + Metoclopramide | Increased risk of extrapyramidal reaction and neuroleptic malignant syndrome | 1 (0.1) |
Citalopram + Metoclopramide | Increased risk of extrapyramidal reaction and neuroleptic malignant syndrome | 1 (0.1) |
Oxybutynin + Potassium | Increased risk of gastrointestinal lesions | 1 (0.1) |
Major drug interactions | ||
Heparin + Aspirin | Increased risk of bleeding | 82 (6.0) |
Aspirin + Furosemide | Reduced diuretic effectiveness and possible nephrotoxicity | 52 (3.8) |
Polyethylene glycol + Senna | Increased risk of mucosal ulceration or ischemic colitis | 39 (2.9) |
Aspirin + Metformin | Increased risk of hypoglycemia | 20 (1.5) |
Aspirin + Digoxin | Increased serum concentration of digoxin; prolonged half-life of digoxin | 17 (1.3) |
Clopidogrel + Heparin | Increased risk of bleeding | 14 (1.0) |
Sertraline + Aspirin | Increased risk of bleeding | 12 (0.9) |
Citalopram + Aspirin | Increased risk of bleeding | 12 (0.9) |
Citalopram + Heparin | Increased risk of bleeding | 12 (0.9) |
Clopidogrel + Omeprazole | Reduced plasma concentrations of clopidogrel active metabolite and reduced antiplatelet activity | 12 (0.9) |
Data are presented as n (%).